Cassella James V Insider Trades

Insider Trading History

Track insider trading activity for Cassella James V. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Development Officer
Holding Value $3.74M 215,000 shares
Last Trade
Feb 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.27M 215,000 shares
$10.56
$17.38
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Development Officer
Holding Value $4.48M 257,500 shares
Last Trade
Feb 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.09M 257,500 shares
$4.22
$17.38
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Development Officer
Holding Value $6.95M 400,000 shares
Last Trade
Sep 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.34M 400,000 shares
$3.34
$17.38
Trevi Therapeutics
Trevi Therapeutics TRVI
Director
Holding Value $521k 30,000 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$83.1k 30,000 shares
$2.77
$17.38
Trevi Therapeutics
Trevi Therapeutics TRVI
Director
Holding Value $521k 30,000 shares
Last Trade
Jun 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$68.1k 30,000 shares
$2.27
$17.38
Concert Pharmaceuticals
Concert Pharmaceuticals CNCE
Chief Development Officer
Holding Value $0 0 shares
Last Trade
Mar 06, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$4.85M 579,796 shares
$8.37
$8.37
Concert Pharmaceuticals
Concert Pharmaceuticals CNCE
Chief Development Officer
Holding Value $0 0 shares
Last Trade
Mar 06, 2023 Sale (Tender)Reported as Tender on SEC Form 4.
$645k 80,595 shares
$8.00
$8.37
Concert Pharmaceuticals
Concert Pharmaceuticals CNCE
Chief Development Officer
Holding Value $1.45M 173,061 shares
Last Trade
Feb 15, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$31.4k 3,762 shares
$8.34
$8.37
Concert Pharmaceuticals
Concert Pharmaceuticals CNCE
Chief Development Officer
Holding Value $1.48M 176,823 shares
Last Trade
Jan 30, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$84.4k 10,106 shares
$8.35
$8.37
Concert Pharmaceuticals
Concert Pharmaceuticals CNCE
Chief Development Officer
Holding Value $1.56M 186,929 shares
Last Trade
Jan 06, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$21k 2,893 shares
$7.25
$8.37
Trevi Therapeutics
Trevi Therapeutics TRVI
Director
Holding Value $348k 20,000 shares
Last Trade
Jun 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45.4k 20,000 shares
$2.27
$17.38
Trevi Therapeutics
Trevi Therapeutics TRVI
Director
Holding Value $348k 20,000 shares
Last Trade
Jun 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45.4k 20,000 shares
$2.27
$17.38
Concert Pharmaceuticals
Concert Pharmaceuticals CNCE
Chief Development Officer
Holding Value $1.59M 189,822 shares
Last Trade
Feb 14, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$11.6k 3,762 shares
$3.09
$8.37
Concert Pharmaceuticals
Concert Pharmaceuticals CNCE
Chief Development Officer
Holding Value $1.62M 193,584 shares
Last Trade
Jan 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$319k 110,500 shares
$2.89
$8.37
Concert Pharmaceuticals
Concert Pharmaceuticals CNCE
Chief Development Officer
Holding Value $695k 83,084 shares
Last Trade
Jan 05, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$9.23k 2,894 shares
$3.19
$8.37
Concert Pharmaceuticals
Concert Pharmaceuticals CNCE
Chief Development Officer
Holding Value $720k 85,978 shares
Last Trade
Aug 16, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$26.5k 8,086 shares
$3.28
$8.37
Trevi Therapeutics
Trevi Therapeutics TRVI
Director
Holding Value $348k 20,000 shares
Last Trade
Jun 16, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45k 20,000 shares
$2.25
$17.38
Concert Pharmaceuticals
Concert Pharmaceuticals CNCE
Chief Development Officer
Holding Value $787k 94,064 shares
Last Trade
Feb 16, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$27.5k 3,763 shares
$7.32
$8.37
Concert Pharmaceuticals
Concert Pharmaceuticals CNCE
Chief Development Officer
Holding Value $819k 97,827 shares
Last Trade
Jan 05, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.07M 82,100 shares
$13.07
$8.37
Concert Pharmaceuticals
Concert Pharmaceuticals CNCE
Chief Development Officer
Holding Value $637k 76,127 shares
Last Trade
Aug 17, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$45.2k 4,354 shares
$10.37
$8.37

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up